Latest filing published 09 Jul 2026 for BridgeBio Pharma, Inc., €11.5M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jennifer Cook: trading record in brief
All filings by Jennifer Cook on record concern BridgeBio Pharma, Inc. In total, 4 filings cover trades dated from 15 June 2026 to 9 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 9 July 2026: a transaction of €11.5M, in BridgeBio Pharma, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jennifer Cook
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 148,589 shares@ US$88.53960.075% mcap100.0% of flowCommonSEC144:0001950047-26-006979
- 37,167 shares@ US$70.000.016% mcap16.4% of flowCommonSEC144:0001950047-26-006442
- 2,196 shares@ US$68.570.0009% mcap0.9% of flowCommonSEC144:0001950047-26-006434
- 90,240 shares@ US$66.6241CommonSEC144:0001950047-26-006155
4 of 4 declarations
